Verdad Advisers’s iBio IBIO Stock Holding History

Verdad Advisers’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$523K	Buy	298,927 +242,609	+431%	+$434K	0.5%	75
2026 Q1	$107K	Buy	+56,318	New	+$131K	0.12%	153

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Verdad Advisers's IBIO Position: Q2 2026 in Review

Verdad Advisers increased its iBio (IBIO) stake by 431% in Q2 2026, buying an estimated $434K and bringing the position to 298,927 shares worth $523K. The position accounts for 0.5% of the portfolio, ranked #75.

Verdad Advisers first reported a position in IBIO in Q1 2026 and has held it in 2 quarters since. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

Verdad Advisers held 298,927 shares of iBio worth $523K as of Q2 2026.
Verdad Advisers bought 242,609 iBio shares in Q2 2026, an estimated $434K.
iBio made up 0.5% of Verdad Advisers's portfolio in Q2 2026, its #75 holding.
Verdad Advisers first reported a position in iBio in Q1 2026 and has held it in 2 quarters since.
55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.